scholarly journals A Case of Covered Perforation of Cancer of the Transverse Colon with Intramesocolic Granulation and Jejunum Stenosis.

2001 ◽  
Vol 62 (1) ◽  
pp. 225-230
Author(s):  
Yoshikazu SAKAKI ◽  
Akihiro SAKATA ◽  
Suguru KIMURA ◽  
Takanao SUMI ◽  
Tuneaki WATANABE
Keyword(s):  
Transverse Colon ◽  
Covered Perforation

Tuberculosis of the Transverse Colon

1959 ◽  
Vol 36 (5) ◽  
pp. 698-701 ◽  
Author(s):  
Allan R. Aronson ◽  
Louis R. Slattery
Keyword(s):  
Transverse Colon

scholarly journals Cost Analysis of Endoscopic Submucosal Dissection for the Treatment of Colorectal Lesions in China

2019 ◽  
Vol 2019 ◽  
pp. 1-7
Author(s):  
Ning Cui ◽  
Yu Zhao ◽  
Honggang Yu
Keyword(s):  
Colorectal Cancer ◽  
Cost Analysis ◽  
Endoscopic Submucosal Dissection ◽  
Transverse Colon ◽  
Surgical Margin ◽  
Positive Surgical Margin ◽  
Labor Costs ◽  
Positive Surgical Margins ◽  
Submucosal Dissection ◽  
Treatment Medication

Aim. The aim of the study was to evaluate costs associated with colonic endoscopic submucosal dissection (ESD) for treatment of colorectal cancer. Methods. The study is a retrospective analysis of data on 395 patients treated by colonic ESD. Results. The operation, consumable items, and medication accounted for 71% of the total costs for colonic ESD treatment. Medication and consumable items’ costs were higher if lesions occurred in the transverse colon and right hemicolon compared to the left hemicolon. Medication, consumable items, and total costs were higher for larger lesions. Lesion numbers and carcinoma were associated with higher medication, consumable items, operation, and total costs. Positive surgical margins and complications of hemorrhage or perforation were positively correlated with higher costs for medication, consumable items, and total costs. Conclusion. Labor costs for doctors and nurses remain low in China. Costs for medication and consumable items were higher for treatment involving the transverse colon or right hemicolon (vs. the left hemicolon), larger lesions, carcinoma, and a positive surgical margin. A benchmark cost estimate for ESD treatment including 4 days of postoperative hospitalization was determined to be approximately 5400 USD.

scholarly journals Transverse colonic volvulus due to mesenteric fibromatosis: a case report

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Akihiro Yoshida ◽  
Yasutake Uchima ◽  
Naoki Hosaka ◽  
Kosuke Minaga ◽  
Masatoshi Kudo
Keyword(s):  
Transverse Colon ◽  
Colonic Neoplasms ◽  
Right Hemicolectomy ◽  
Large Bowel Obstruction ◽  
Postoperative Recovery ◽  
Thyroid Tumor ◽  
Hepatic Flexure ◽  
Colonic Volvulus ◽  
Mesenteric Fibromatosis ◽  
Histopathological Results

Abstract Background Colonic volvulus, a condition in which a colonic segment partially twists around its base, is the third leading cause of large bowel obstruction after colonic neoplasms and diverticular disease. However, volvulus of the transverse colon is the rarest type of large intestinal volvulus. Moreover, the occurrence of transverse colonic volvulus secondary to a benign tumor originating from outside the intestine has never been reported. We hereby report a case of transverse colonic volvulus caused by mesenteric fibromatosis. Case presentation A 53-year-old female with a history of rheumatoid arthritis and thyroid tumor presented with abdominal pain for 1 day. Abdominal computed tomography revealed intestinal torsion at the hepatic flexure. Twisted and obstructed mucosa of the transverse colon was observed during colonoscopy, but no tumor invasion of the mucosal surface was detected. A solid mass of a mesenteric origin with involvement of the transverse colon was observed during surgery. The mass was diagnosed surgically as transverse colonic volvulus induced by a mesenteric tumor. Hence, the patient underwent a right hemicolectomy. Histopathological results indicated mesenteric desmoid-type fibromatosis. The postoperative recovery was uneventful, and the patient was discharged 8 days after surgery. Conclusions Although mesenteric fibromatosis is rare, this disease should be considered when managing transverse colonic volvulus resulting from nonmucosal tumors.

scholarly journals Ischemic volvulus of the transverse colon caused by intestinal malrotation: A case report

2021 ◽  
pp. 105971
Author(s):  
Mounir Bouali ◽  
Karim Yaqine ◽  
Abdelilah Elbakouri ◽  
Fatimazahra Bensard ◽  
Khalid Elhattabi ◽  
...  
Keyword(s):  
Case Report ◽  
Transverse Colon ◽  
Intestinal Malrotation

scholarly journals A147 PRIMARY COLONIC MANTLE CELL LYMPHOMA: A RARE ENTITY

2021 ◽  
Vol 4 (Supplement_1) ◽  
pp. 138-140
Author(s):  
K Donaldson ◽  
S Nassiri ◽  
D Chahal ◽  
M F Byrne
Keyword(s):  
Case Report ◽  
Cyclin D1 ◽  
Mantle Cell Lymphoma ◽  
Transverse Colon ◽  
Cell Lymphoma ◽  
Rapid Progression ◽  
Rare Entity ◽  
Gi Bleeding ◽  
Gi Tract ◽  
Mantle Cell

Abstract Background Mantle cell lymphoma (MCL) is an aggressive subtype of B-cell non-Hodgkin lymphoma (NHL), often diagnosed at later stages with secondary gastrointestinal (GI) involvement. Primary GI MCL is rare and is not often discussed in the literature. Aims To increase awareness of a rare condition that is likely to be encountered but can be challenging to diagnose. Methods Case report and review of the literature. Results Case Report A 78-year-old man with multiple untreated vascular risk factors including atrial fibrillation and type 2 diabetes presented with acute onset left hemiplegia, dysarthria, and imaging consistent with a left pontine stroke. As part of his workup he underwent a CT abdomen/pelvis identifying an 11 x 5 cm intraluminal mass in the transverse colon. Previous screening colonoscopies, for family history of colon cancer, were notable for tubular adenomas without high-grade dysplasia at 13, 12, 10, 7, and 2 years prior to admission. The patient had 16 pounds of weight loss without other constitutional symptoms, change in bowel habits or evidence of GI bleeding. Bloodwork was notable for microcytic anemia (Hemoglobin 91 g/L, MCV 75 fL), from a normal baseline one year prior, without other cytopenias. C-reactive protein (44 mg/L) and GGT (164 U/L) were elevated. Other liver enzymes, lactate dehydrogenase, and electrolytes were normal. Colonoscopy revealed numerous polypoid lesions throughout the entire colon and a large non-obstructive mass with submucosal appearance in the transverse colon. Biopsies were taken from the large mass and one of the smaller polypoid lesions. Histology showed a sheet-like infiltrate of small lymphocytes within the lamina propria. Immunohistochemical staining was positive for CD20, BCL2, Cyclin D1, equivocal for CD5, and negative for BCL6 and CD3. Ki67 index approached 30%. A diagnosis of colonic MCL was made. Literature Review Primary MCL of the GI tract is rare, accounting for only 1 to 4% of all GI malignancies. There is a male and Caucasian predominance with a median age of 68 years at diagnosis. Presenting complaints may include abdominal pain, anorexia, and GI bleeding. Typical endoscopic features are small nodular or polypoid tumors, between 2mm and 2 cm in size, along one or more segments of the GI tract referred to as multiple lymphomatous polyposis (MLP). A single colonic mass is infrequently seen, highlighting the importance of endoscopy for diagnosis, as subtle findings may be missed on radiographic evaluation. Biopsies for immunohistochemistry are essential to distinguish MCL from other NHLs, as almost all cases express cyclin D1. Despite aggressive immunochemotherapy, prognosis is often poor due to MCL’s rapid progression and early relapse. Conclusions Primary GI MCL is a rare entity. Awareness is essential as evaluation and management differ from lymphoma at other sites, and other GI malignancies. Funding Agencies None

Sign in / Sign up

Export Citation Format

Share Document